Literature DB >> 21811961

Skeletal muscle insulin resistance in morbid obesity: the role of interleukin-6 and leptin.

P Mitrou1, V Lambadiari, E Maratou, E Boutati, V Komesidou, A Papakonstantinou, S A Raptis, G Dimitriadis.   

Abstract

BACKGROUND: Although insulin resistance in obesity is established, the link between excess body fat and skeletal muscle insulin resistance is obscure. The aim of this study was to investigate whether cytokines secreted from the subcutaneous adipose tissue are related to the sensitivity of glucose metabolism to insulin in skeletal muscle.
METHODS: A meal was given to 14 obese and 10 non-obese women. Plasma samples were taken for 360 min from a forearm vein and from the radial artery for glucose and insulin measurements. Interleukin-6, leptin, TNFα, resistin and adiponectin were measured preprandially from the radial artery and from the superficial epigastric vein. Forearm blood flow was measured with plethysmography.
RESULTS: (1) In obese vs non-obese: (a) Glucose uptake by skeletal muscle was decreased (AUC (0-360)369 ± 55 vs. 877 ± 146 μmol/100 g tissue, p=0.001) (b) arterial interleukin-6 (2.5 ± 0.5 vs. 1 ± 0.1 pg/ml, p=0.013) and subcutaneous venous interleukin-6 (5 ± 0.5 vs. 3.4 ± 0.5 pg/ml, p=0.027) were increased (c) arterial leptin (63 ± 7 vs. 5 ± 0.6 ng/ml, p<0.0001) and subcutaneous venous leptin 80 ± 8 vs. 6.5 ± 0.7 ng/ml, p<0.0001) were increased. (2) Arterial interleukin-6 (p=0.002) and subcutaneous venous interleukin-6 (p=0.014) were negatively associated with forearm glucose uptake in obese. (3) No association was found between leptin and forearm glucose uptake, after correcting with fat mass.
CONCLUSIONS: In morbid obesity: (1) Subcutaneous adipose tissue releases interleukin-6 which could then mediate insulin resistance in skeletal muscle. (2) Although there is increased secretion of leptin by the subcutaneous adipose tissue, leptin levels are not correlated to the sensitivity of glucose metabolism to insulin in muscle. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811961     DOI: 10.1055/s-0030-1269846

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

Review 1.  The role of leptin in obesity and the potential for leptin replacement therapy.

Authors:  Helin Feng; Lihua Zheng; Zhangying Feng; Yaheng Zhao; Ning Zhang
Journal:  Endocrine       Date:  2012-12-29       Impact factor: 3.633

2.  Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS).

Authors:  Wenting Qi; Yan Jiang; Wei Liu; Yue Chi; Ruizhi Jiajue; Qianqian Pang; Ou Wang; Mei Li; Xiaoping Xing; Wei Yu; Weibo Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

3.  Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk.

Authors:  David D McManus; Lea M Beaulieu; Eric Mick; Kahraman Tanriverdi; Martin G Larson; John F Keaney; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

4.  Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor α in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity.

Authors:  Jessica S Ross; Wei Hu; Bess Rosen; Ashley J Snider; Lina M Obeid; L Ashley Cowart
Journal:  J Biol Chem       Date:  2013-06-13       Impact factor: 5.157

Review 5.  The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management.

Authors:  Mauricio Krause; Thiago Gomes Heck; Aline Bittencourt; Sofia Pizzato Scomazzon; Philip Newsholme; Rui Curi; Paulo Ivo Homem de Bittencourt
Journal:  Mediators Inflamm       Date:  2015-02-26       Impact factor: 4.711

6.  Postprandial Responses to Lipid and Carbohydrate Ingestion in Repeated Subcutaneous Adipose Tissue Biopsies in Healthy Adults.

Authors:  Aimee L Dordevic; Felicity J Pendergast; Han Morgan; Silas Villas-Boas; Marissa K Caldow; Amy E Larsen; Andrew J Sinclair; David Cameron-Smith
Journal:  Nutrients       Date:  2015-07-01       Impact factor: 5.717

7.  Identification of a selective glucocorticoid receptor ligand for the treatment of chronic inflammation in type 2 diabetes mellitus.

Authors:  Haifeng Tan; Wei Wang; Xiangang Yin; Yao Li; Rui Yin
Journal:  Exp Ther Med       Date:  2014-07-23       Impact factor: 2.447

8.  Plasma ghrelin, adiponectin and leptin levels in obese rats with type 2 diabetes mellitus after sleeve gastrectomy and gastric plication.

Authors:  Laurian Stoica; Ramona Gadea; Dan-Bogdan Navolan; Fulger Lazar; Ciprian Duta; Dana Stoian; Cristi Tarta; Flavius Olaru; Alexandru Isaic; Amadeus Dobrescu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.